HLA-DR3 and DQA1*0401: Possible risk factors in Alzheimer's disease

Alzheimer's Reports

Volumn 2, Issue 2, 1999, Pages 93-97

  Culpan, Doris ^a,b   MacGowan, Sian ^a   Laundy, Godfrey J ^b   Wilcock, Gordon K ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22644451137     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bunce M Taylor CJ Welsh KI (1993). Rapid HLA-DQB Typing by Eight Polymerase Chain Reaction Amplifications with Sequence-Specific Primers (PCR-SSP). Hum Immunol 37, 201-206.
2. ClayTM, CulpanD, Pursall MC et al. (1995). HLA-DQB1 And DQA1 Matching By Ambient Temperature PCR-SSCP. Eur J Immunogenet 22, 467-478.
3. Clayton J and Lonjou C (1997). Allele and haplotype frequencies for HLA loci in various ethnic groups. In: Genetic Diversity of HLA Functional and Medical Implication Volume 1, Workshop. Charron D, ed. EDK, Paris: pp 665-820.
4. Combarros O, Leno C, Oterino A et al. (1998). Gender effect on apolipoprotein E epsilon4 allele-associated risk for sporadic Alzheimer's disease. Acta Neurol Scand 97, 68-71.
5. Corder EH, Saunders AM, Strittmater WJ et al. (1993). Gene dose of apoE type 4 allele and the risk of AD in late onset Families. Science 261, 921-923.
6. Curran M, Middelton D, Edwardson J et al. (1997). HLA-DR antigens associated with major genetic risk for late onset Alzheimers' Disease. NeuroReport 8, 1467-1469.
7. Kuusisto J, Koivisto K, Kervinen K et al. (1994). Association of Apolipoprotein E phenotypes with late onset Alzheimer's disease, population based study. Br Med J 309, 636-638.
8. Me Geer PL, Rogers J and Mc Geer EG (1994). Neuroimmune Mechanisms in Alzheimer's Disease Pathogenesis. Alz Dis Ass Disord 8, 149-158.
9. Mirra SS, Heyman A, McKeel D et al. (1991). The Consortium to Establish a Registry for Alzheimer's Disease Part II Standardisation of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
10. Olerup O and Zetterquist H (1992). HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 39, 225-235.
11. Olerup O, Aldener A and Fogdell A (1993). HLA-DQB1 and-DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 41, 119-134.
12. Payami H, Schellenberg GD, Zareparsi MS ef al. (1997). Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease. Neurology 49, 512-518.
13. Stewart WF, Kawas C, Corrada M and Metter EJ (1997). Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626-632.
14. Wenham PR, Price WH and Blundell G (1991). Apolipoprotein E genotyping by one-stage PCR. Lancet 337, 1158-1159.